Abstract

CLC Number:

R994.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2017/V14/I9/569

[1] 赵世丹, 鲁仲平. 影响个例药品不良反应报告评价的因素[J]. 中国药物警戒, 2012, 9(9):553-555.
[2] 张卫民, 姜晓燕, 魏丽晶,等. 胞二磷胆碱对神经细胞凋亡保护作用[J]. 中国公共卫生, 2007, 23(8):1006-1007.
[3] 刘莉, 石正洪, 鄢琦,等. 胞二磷胆碱治疗急性脑卒中效果的Meta分析[J]. 中国循证医学杂志, 2011, 11(4):404-412.
[4] 关保元, 李建强, 李淑云. 胞二磷胆碱治疗新生儿缺氧缺血性脑病40例疗效观察[J]. 中国实用医药, 2007, 2(17):74.
[5] 黄春林. 胞二磷胆碱的副作用[J]. 医药导报, 1995(5):234.
[6] 蒋霞, 蔡果珍. 胞磷胆碱注射液致不良反应58例文献分析[J]. 中国药房, 2014,25(40):3816-3819.
[7] 田自有, 滕俊, 王茹稼,等. 胞磷胆碱注射液不良反应104例文献分析[J]. 浙江中西医结合杂志, 2014, 24(4):363-366.
[8] 李春英. 胞二磷胆碱致精神症状2例报告[J]. 现代诊断与治疗, 2013,24(12):2859-2860.
[9] 田义江. 胞二磷胆碱诱发精神病发作1例[J]. 菏泽医学专科学校学报, 2004, 16(1):90.
[10] 安丽荣, 郭艳芹, 毕鹏翔. 胞二磷胆碱致变态反应2例[C]// 医药导报编委会成立大会暨2009年度全国医药学术交流会和临床药学与药学服务研究进展培训班论文集. 2009:198.
[11] 王文慧, 李明明. 胞二磷胆碱致过敏反应1例[J]. 西北国防医学杂志, 2012, 33(3):261.
[12] 王曙光, 李成建, 赵辉. 胞磷胆碱所致哮喘[J]. 中国误诊学杂志, 2011, 11(23):5628.
[13] 杨文, 赵勇. 阿司咪唑治疗氯氮平所致流涎[J]. 临床精神医学杂志, 2009, 19(2):131-132.
[14] 陆承兴. 西咪替丁治疗氯氮平所致流涎[J]. 中国新药与临床杂志, 1997,16(6):373.
[15] 庄红艳, 刘珊珊, 果伟,等. 121例老年精神科药品不良反应报告分析[J]. 中国药物警戒, 2017, 14(2):105-108.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.